Allergan’s portfolio features best-in-class facial aesthetics, body contouring, plastic surgery and regenerative medicine offerings, which includes products such as BOTOX Cosmetic®, CoolSculpting®, Natrelle® and more.
Revance is more than a biotechnology company taking an innovative approach to neurotoxin delivery. We are the integrated sum of our many strengths.
Deep knowledge of drug development, scientific acumen, and prior commercialization experience will enable our team of experts to bring to market a focused portfolio of product candidates that achieve multiple strategic objectives.
Our trajectory to commercial success begins with the development and delivery of our next-generation neurotoxin, daxibotulinumtoxinA, Revance’s highly purified botulinum toxin type A.
ALASTIN Skincare, Inc. is a specialty aesthetics company dedicated to developing and marketing innovative, clinically-tested physician-dispensed skin care products with proprietary TriHex Technology® that enhance, protect, and maintain healthy skin for a lifetime. In addition to its award-winning daily skin care line, Alastin Skincare has created a new category in the aesthetic space with its leading line of procedure products that prepare skin for rejuvenating procedures, help skin heal after procedures, and optimize the patient experience and outcomes.
For over 12 years, Colorescience has been blurring the lines between makeup and skincare to bring immediate beauty today while improving and protecting skin for tomorrow. Originally crafted for the most vulnerable post-procedure skin and trusted by thousands of physicians, the brand has now become a go-to for consumers and media for their everyday products for skin health. All of our products are created using only substantiated ingredients in their purest form and include daily protection from UV Rays and environmental stressors.
With 40+ years representing life sciences clients, Cooley has been at the forefront working alongside leading life sciences companies across the globe. Our clients include high growth and mature companies, entrepreneurs, venture capitalists and financial institutions. We rank #1 for life sciences and healthcare venture financings, #1 for issuer-side life sciences IPOs, Top 5 for biotech and pharma M&A and have the largest life sciences IP team in the US. We have an unrivaled corporate partnering and licensing practice with a global transactions footprint and a unique and extensive understanding of biotech’s and pharma’s perspective, needs and deal drivers.
Endo Pharmaceuticals Inc., headquartered in Malvern, PA, develops and markets high-value, quality branded pharmaceutical products for patients in need. Endo Pharmaceuticals’ specialty portfolio includes products for urology, men’s health, orthopedics and endocrinology, with product development underway in medical aesthetics. Endo Pharmaceuticals is an operating company of Endo International plc (NASDAQ: ENDP), a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients through excellence in development, manufacturing and commercialization.
|Guggenheim Securities is the investment banking and capital markets business of Guggenheim Partners, a global investment and advisory firm. Guggenheim Securities offers services that fall into four broad categories: Advisory, Financing, Sales and Trading, and Research. Guggenheim Securities is headquartered in New York, with additional offices in Chicago, Boston, Atlanta, Los Angeles, San Francisco, and Houston.|
PatientPop is the proven all-in-one practice growth platform that empowers single- and multi-provider healthcare practices to thrive in the digital age. PatientPop combines the tools needed to build online presence and enhance each touchpoint in the patient journey, from first impression online to post-appointment follow-up.
Healthcare providers throughout the U.S. turn to PatientPop to increase their web presence, build a modern website, and improve search rankings. PatientPop also offers online scheduling, appointment reminders, and patient satisfaction surveys. With PatientPop, providers can grow their practice, modernize the patient experience, and streamline their front office.
Red Spot Interactive
Red Spot Interactive (RSI) provides medical marketing software, marketing services, and patient scheduling services measured by its practices’ exact return on investment (ROI). Through the proprietary integration of practice management, EMR, and marketing data, RSI is able to understand, automate, and improve its client’s ROI associated with the patient acquisition and retention process. In addition, RSI provides a fully automated patient retention suite which further increases practice profits and scale.
ZO Skin Health
ZO Skin Health, Inc. develops and delivers innovative skincare solutions that optimize skin health based on the latest advances in skin therapy technologies, unique delivery systems, bioengineered complexes, and exclusive formulations. By providing comprehensive skincare programs for physicians and their patients, ZO Skin Health, Inc. bridges the gap between therapeutic treatments and daily care, allowing patients to experience continuously healthy skin regardless of their age, ethnicity or unique skin condition.
MedEsthetics magazine serves dermatologists, plastic surgeons, medspas and other healthcare professionals who offer noninvasive and minimally invasive cosmetic procedures. Each issue includes business profiles, marketing tips, practice management solutions, coverage of the latest treatment tools and techniques, and information on legal issues affecting the medical aesthetics industry.
NewBeauty is the Beauty Authority. Our mission is to inspire, educate and guide women to make smart, informed and confident beauty choices. NewBeauty delivers cutting-edge information on the latest technologies, advanced beauty solutions, breakthrough products, cosmetic enhancement procedures and leading professionals as well as advancements in wellness, fitness, and nutrition. Our powerful editorial content and expert-approved advice fill a void where in-depth, unbiased and trusted information is impossible to find.
PRIME is the leading scientific journal within this market through quality peer-reviewed editorial, the most engaged and qualified circulation, and leading publication design. PRIME works in partnership with the leading physicians, suppliers and societies to offer timely and valuable content to help educate and inform the aesthetic market.